Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Joe Wesley who wrote (1960)	5/4/1998 7:27:00 PM
From: Perry	Read Replies (1) \| Respond to of 4676

<<Miljenko: If Isis has anything to say about folic acid it may be good to get it out now. Amateur>> Can you please explain this comment. Thanks, Perry

To: Joe Wesley who wrote (1960)	5/4/1998 8:56:00 PM
From: Miljenko Zuanic	Read Replies (2) \| Respond to of 4676

Hi Amateur: >>If Isis has anything to say about folic acid it may be good to get it out now.<< For short hype, yes. In long run I will prefer to see revised Novartis agreement with sec. gen. antisense and improved/targeted formulation. We now that folic acid may be included in active targeting and formulation, so I think that it is better to keep info between Isis/Novartis. Isis will have three presentations at ASCO conference, so this will be good place to inform researcher and clinicians about perspective beyond initial PI cancer data. BTW, I am not fun of BLSI/ENMD proteins. Miljenko PS: Let me know about your schedule for Isis OH. I am very busy at work (I want to finish work ahead of summer brake and have few weeks for Europe visit), but will menage Friday somehow.